Problems › Business Transformation Consulting › Fintech
In fintech the point where transformation work collapses is the diagnosis, which is commissioned from the advisers who will later be paid to implement whatever they recommend. The version of this question that applies to fintech companies is not the generic one. Lending fixed the P&L and converts revenue worth a 7x multiple into revenue worth a 2x multiple — so an answer that ignores blended take rate will be confidently wrong. The analysis has to start from charge-off rate and contribution margin rather than from revenue.
In fintech the point where transformation work collapses is the diagnosis, which is commissioned from the advisers who will later be paid to implement whatever they recommend. The version of this question that applies to fintech companies is not the generic one. Lending fixed the P&L and converts revenue worth a 7x multiple into revenue worth a 2x multiple — so an answer that ignores blended take rate will be confidently wrong. The analysis has to start from charge-off rate and contribution margin rather than from revenue.
A fintech transformation engagement combines three distinct steps: determining why blended take rate and contribution margin sit where they do, selecting which adjustments to charge-off rate or CAC by channel will move those numbers, and then supplying the capacity to carry out the changes. Providers package the steps together because the review phase is priced to recover cost while the economics are recovered in the delivery phase that follows. The result is that the review tends to surface problems whose scale justifies a large subsequent engagement.
Repeated shortfalls in these programmes after years of repetition indicate the breakdown occurs before any workstream begins. The conversion of a question about which payment flows actually cover their cost of capital and which of them can be altered inside the current warehouse facility into a set of project plans happens before the question has been answered.
The practical test is whether the CEO or CFO can already state the two or three metrics, such as blended take rate or charge-off rate, that must be corrected and in what sequence, with the arithmetic attached. When that list exists the requirement is delivery capacity. When it does not, every pound spent on implementation resources before the diagnosis exists is spent embedding the present margin shortfalls more deeply.
Corporate Strategy & Transformation supplies the missing first half: an allocation of the $84M net revenue across the 28,000 merchants and $9.4B of payment volume that shows which segments fund which costs and which changes should occur first. It does not place teams inside the business. When the accurate conclusion is that a large implementation team is required, it states that directly, which is cheaper than discovering it on the first major invoice.
These three together are the signature. One on its own usually points somewhere else.
✓ Talk of changing operations starts before anyone has settled whether the current charge-off rate or take rate is the binding constraint on contribution margin.
✓ A project timeline is circulated while the contribution margin by channel and CAC by channel remain uncalculated.
✓ Workstreams are labelled after existing teams rather than after movements required in TPV or warehouse facility utilisation.
The move that usually makes it worse. Commissioning the initial review from the firm that will later bid to deliver the remedy, which reliably produces a review whose scale matches the size of the remedy it can sell.
It is for you if you run or finance a fintech and the word "transformation" is being used before anyone has agreed what is broken. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on a fintech. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is Verrano Pay, a sample company profile used for testing rather than a customer — $84M net revenue, 28,000 merchants, $9.4B of payment volume.
Excerpt from a real Percision run · Quick Market Scan · sample company profile
The move. Lift lending take-up from 14% to 22% while keeping charge-offs below 9.0% by leveraging the existing vertical integrations and $9.4B TPV dataset.
| Investment required | $2.8-3.4M total (no new equity) |
| Expected return | Incremental lending revenue of $8.4-11.2M annually at 70% contribution margin yields 2.1-2.8× cash-on-cash return within 24 months on the $3.4M investment |
| Revenue, year 1 | $92-96M FY2026 |
| Revenue, year 2 | $101-110M FY2027 |
| Revenue, year 3 | $118-130M FY2028 |
| Exit criteria | Strategy must be abandoned or pivoted if, within 12 months, (a) take-up has not reached 16% OR (b) charge-off has exceeded 8.7% for two consecutive quarters, OR (c) any one of the three platform partners terminates its integration agreement. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Corporate Strategy & Transformation, one of 29 engagements the platform runs. For fintech companies it works through blended take rate, charge-off rate, contribution margin and CAC by channel, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
For a mid-market company the diagnostic phase alone is commonly £75k–£250k over six to ten weeks, and the delivery phase that follows is usually several multiples of that. Large-firm day rates run roughly £1,500–£3,500 for a consultant and £4,000–£8,000 for a partner, and a typical team blends the two so the effective rate lands somewhere in the middle. The number that matters is not the day rate, though — it is the ratio of diagnosis to delivery, because that is where the scope is set.
No, and any tool that claims otherwise is selling you something. Software cannot run a programme office, hold a difficult conversation with a divisional MD, or supply forty people for nine months. What it can do is produce the analysis that decides whether you need those things, and what they should be pointed at — which is the part that is most often rushed and most expensive to get wrong.
Buy the diagnosis separately from whoever will deliver, and write the decision down before you take delivery bids. Once the two or three changes are named and the arithmetic is on paper, the delivery tender is a procurement exercise with a fixed brief. Once they are not, the tender sets its own brief, and it is always a larger one.
Materially, yes. Lending fixed the P&L and converts revenue worth a 7x multiple into revenue worth a 2x multiple — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are blended take rate, charge-off rate, contribution margin, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on blended take rate and charge-off rate. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Português · Français · Italiano · Nederlands · 日本語 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית